Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Everolimus × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Carcinoma, Renal Cell 6 Neuroendocrine Tumors 5 Neoplasm Metastasis 4 Tuberous Sclerosis 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thymus Neoplasms 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Pheochromocytoma 1 Phase IB 1 Paraganglioma 1 Ovarian Neoplasms 1 Nevus 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Lymphoma 1

Interventions

Cyclophosphamide 21 Rituximab 18 fludarabine 15 obinutuzumab 10 pirtobrutinib 9 fludarabine phosphate 9 venetoclax 8 ibrutinib 7 Prednisone 7 Lenalidomide 7 Biopsy 7 tocilizumab 6 glofitamab 6 Specimen Handling 6 Immunotherapy, Adoptive 6 polatuzumab vedotin 5 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 X-Rays 4 Tacrolimus 4 Phantoms, Imaging 4 Doxorubicin 4 pembrolizumab 3 palbociclib 3 olaparib 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Vincristine 3 Vemurafenib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡